Rocket Lab (NASDAQ:RKLB) Stock Rating Reaffirmed as Buy by TD Cowen

Rocket Lab (NASDAQ:RKLB – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at TD Cowen in a research report issued on Thursday, Benzinga reports. They currently have a $90.00 target price on the rocket manufacturer’s stock. TD Cowen’s price target indicates a potential upside of 75.23% from the company’s previous close.

RKLB has been the topic of several other research reports. Roth Capital reiterated a “buy” rating on shares of Rocket Lab in a research report on Thursday. Needham & Company LLC reiterated a “buy” rating on shares of Rocket Lab in a research report on Tuesday, August 11th. Piper Sandler started coverage on Rocket Lab in a research report on Wednesday, July 15th. They set a “neutral” rating and a $83.00 price objective on the stock. Cantor Fitzgerald reiterated a “mixed” rating and set a $122.00 price objective on shares of Rocket Lab in a research report on Thursday, October 15th. Finally, Barclays started coverage on Rocket Lab in a research report on Friday, October 9th. They set an “overweight” rating and a $85.00 price objective on the stock. Three equities research analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $102.05.

Get Our Latest Analysis on Rocket Lab

Rocket Lab Trading Up 1.0%

RKLB opened at $51.36 on Thursday. Rocket Lab has a 1-year low of $37.57 and a 1-year high of $151.00. The stock’s fifty day simple moving average is $68.28 and its 200 day simple moving average is $84.15. The company has a debt-to-equity ratio of 0.01, a quick ratio of 4.98 and a current ratio of 5.48.

Rocket Lab (NASDAQ:RKLB – Get Free Report) last posted its quarterly earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.02). Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. The business had revenue of $234.07 million during the quarter, compared to the consensus estimate of $231.62 million. Equities research analysts expect that Rocket Lab will post -0.20 EPS for the current fiscal year.

Insider Activity

In other Rocket Lab news, insider Frank Klein sold 45,692 shares of the stock in a transaction on Monday, August 24th. The stock was sold at an average price of $69.63, for a total transaction of $3,181,533.96. Following the transaction, the insider owned 961,295 shares in the company, valued at $66,934,970.85. This trade represents a 4.54% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CAO Agostino Ricupati sold 669 shares of the stock in a transaction on Monday, August 24th. The stock was sold at an average price of $69.63, for a total value of $46,582.47. Following the transaction, the chief accounting officer owned 26,863 shares in the company, valued at $1,870,470.69. The trade was a 2.43% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders have sold 400,749 shares of company stock worth $26,964,474. Corporate insiders own 8.40% of the company’s stock.

Institutional Trading of Rocket Lab

Large investors have recently modified their holdings of the stock. BlackRock Inc. acquired a new stake in Rocket Lab in the second quarter valued at about $4,124,970,000. Bank of New York Mellon Corp acquired a new stake in Rocket Lab in the second quarter valued at about $245,764,000. Bank of America Corp DE acquired a new stake in Rocket Lab in the second quarter valued at about $437,280,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of Rocket Lab by 14.8% during the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,737,451 shares of the rocket manufacturer’s stock valued at $278,262,000 after purchasing an additional 352,094 shares in the last quarter. Finally, Amundi boosted its stake in shares of Rocket Lab by 22.2% during the second quarter. Amundi now owns 2,180,748 shares of the rocket manufacturer’s stock valued at $221,673,000 after purchasing an additional 396,639 shares in the last quarter. 71.78% of the stock is owned by institutional investors and hedge funds.

Key Stories Impacting Rocket Lab

Here are the key news stories impacting Rocket Lab this week:

  • Positive Sentiment: Rocket Lab’s backlog has grown to approximately $2.3 billion, up 137% year over year, providing visibility for its existing launch and space-systems businesses. Supporters say strong revenue growth, cash reserves and Electron contracts can help sustain the company while Neutron development continues. Why Rocket Lab’s Recent Fall Is Overblown
  • Positive Sentiment: Cantor Fitzgerald maintained an Overweight rating and kept its price target unchanged, signaling that at least one analyst views the selloff as excessive. Some investors are also using the decline to increase their positions. Rocket Lab Stock Climbs: What’s Happening?
  • Neutral Sentiment: Iridium Communications reported that stockholders approved its pending acquisition by Rocket Lab. The approval advances the strategic transaction and could broaden Rocket Lab’s satellite-services capabilities, but investors continue to scrutinize the deal’s execution and financial impact. Iridium Announces Third Quarter 2026 Results
  • Negative Sentiment: Rocket Lab pushed Neutron’s inaugural launch to 2027 after identifying manufacturing and structural problems in key propellant tanks. The company is redesigning portions of the first stage and propellant systems and is manufacturing a replacement forward dome. The delay postpones entry into larger, higher-value missions, increases development uncertainty and leaves Electron and the current backlog carrying more of the near-term growth burden. Does Neutron Delay Change The Bull Case For Rocket Lab?

About Rocket Lab

(Get Free Report)

Rocket Lab USA, Inc is a space and defense company that develops and operates launch vehicles, spacecraft, satellite components and related space systems. The company serves government, commercial and scientific customers seeking access to orbit and other space-based capabilities.

Rocket Lab’s launch business is centered on Electron, a small orbital launch vehicle designed to carry satellites and other payloads into low Earth orbit. The company also develops specialized launch and hypersonic test services through programs such as HASTE, while its Neutron vehicle is intended to provide larger payload capacity and support future commercial and government missions.

Through its space systems business, Rocket Lab produces satellite platforms, flight computers, power systems, solar cells, reaction wheels, separation systems, radios and other components used in spacecraft.

Read More

Analyst Recommendations for Rocket Lab (NASDAQ:RKLB)

Receive News & Ratings for Rocket Lab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rocket Lab and related companies with MarketBeat.com's FREE daily email newsletter.